🎉 M&A multiples are live!
Check it out!

Haleon Valuation Multiples

Discover revenue and EBITDA valuation multiples for Haleon and similar public comparables like Sarantis Group, Lavipharm, and EZZ Life Science.

Haleon Overview

About Haleon

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.


Founded

2021

HQ

United Kingdom of Great Britain and Northern Ireland
Employees

24.6K+

Website

haleon.com

Financials

LTM Revenue $14.5B

LTM EBITDA $3.6B

EV

$53.7B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Haleon Financials

Haleon has a last 12-month revenue of $14.5B and a last 12-month EBITDA of $3.6B.

In the most recent fiscal year, Haleon achieved revenue of $14.5B and an EBITDA of $3.4B.

Haleon expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Haleon valuation multiples based on analyst estimates

Haleon P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $14.6B $14.5B XXX XXX XXX
Gross Profit $8.5B $8.7B XXX XXX XXX
Gross Margin 58% 60% XXX XXX XXX
EBITDA $3.0B $3.4B XXX XXX XXX
EBITDA Margin 21% 23% XXX XXX XXX
Net Profit $1.4B $1.4B XXX XXX XXX
Net Margin 9% 9% XXX XXX XXX
Net Debt $12.5B $10.7B XXX XXX XXX

Financial data powered by Morningstar, Inc.

Haleon Stock Performance

As of April 15, 2025, Haleon's stock price is GBP 4 (or $5).

Haleon has current market cap of GBP 33.8B (or $43.5B), and EV of GBP 41.7B (or $53.7B).

See Haleon trading valuation data

Haleon Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$53.7B $43.5B XXX XXX XXX XXX $0.23

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Haleon Valuation Multiples

As of April 15, 2025, Haleon has market cap of $43.5B and EV of $53.7B.

Haleon's trades at 3.7x LTM EV/Revenue multiple, and 14.7x LTM EBITDA.

Analysts estimate Haleon's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Haleon and 10K+ public comps

Haleon Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $53.7B XXX XXX XXX
EV/Revenue 3.7x XXX XXX XXX
EV/EBITDA 15.9x XXX XXX XXX
P/E 23.4x XXX XXX XXX
P/E/Growth 1.9x XXX XXX XXX
EV/FCF 21.0x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Haleon Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Haleon Valuation Multiples

Haleon's NTM/LTM revenue growth is 3%

Haleon's revenue per employee for the last fiscal year averaged $0.6M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Haleon's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Haleon's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Haleon and other 10K+ public comps

Haleon Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -1% XXX XXX XXX XXX
EBITDA Margin 23% XXX XXX XXX XXX
EBITDA Growth 12% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 26% XXX XXX XXX XXX
Revenue per Employee $0.6M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 40% XXX XXX XXX XXX
R&D Expenses to Revenue 3% XXX XXX XXX XXX
Opex to Revenue 41% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Haleon Public Comps

See public comps and valuation multiples for Health & Beauty and Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Acme United XXX XXX XXX XXX XXX XXX
EZZ Life Science XXX XXX XXX XXX XXX XXX
Live Verdure XXX XXX XXX XXX XXX XXX
Lavipharm XXX XXX XXX XXX XXX XXX
Sarantis Group XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Haleon M&A and Investment Activity

Haleon acquired  XXX companies to date.

Last acquisition by Haleon was  XXXXXXXX, XXXXX XXXXX XXXXXX . Haleon acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Haleon

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Haleon

When was Haleon founded? Haleon was founded in 2021.
Where is Haleon headquartered? Haleon is headquartered in United Kingdom of Great Britain and Northern Ireland.
How many employees does Haleon have? As of today, Haleon has 24.6K+ employees.
Who is the CEO of Haleon? Haleon's CEO is Mr. Brian James McNamara.
Is Haleon publicy listed? Yes, Haleon is a public company listed on LON.
What is the stock symbol of Haleon? Haleon trades under HLN ticker.
When did Haleon go public? Haleon went public in 2022.
Who are competitors of Haleon? Similar companies to Haleon include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm.
What is the current market cap of Haleon? Haleon's current market cap is $43.5B
What is the current revenue of Haleon? Haleon's last 12-month revenue is $14.5B.
What is the current EBITDA of Haleon? Haleon's last 12-month EBITDA is $3.6B.
What is the current EV/Revenue multiple of Haleon? Current revenue multiple of Haleon is 3.7x.
What is the current EV/EBITDA multiple of Haleon? Current EBITDA multiple of Haleon is 14.7x.
What is the current revenue growth of Haleon? Haleon revenue growth between 2023 and 2024 was -1%.
Is Haleon profitable? Yes, Haleon is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.